Guardian Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ECSS
CIM
ATO
Guardian Investment Management's GILD Position: Q2 2026 in Review
Guardian Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,750 shares worth $474K. The position accounts for 0.31% of the portfolio, ranked #46.
Guardian Investment Management first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $885K in Q4 2021. 856 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Guardian Investment Management held 3,750 shares of Gilead Sciences worth $474K as of Q2 2026.
- Guardian Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.31% of Guardian Investment Management's portfolio in Q2 2026, its #46 holding.
- Guardian Investment Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
- Guardian Investment Management's Gilead Sciences position peaked at $885K in Q4 2021.
- 856 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.